Effects of a gluten-free diet on gut microbiota and immune function in healthy adult humans

Gut Microbes

Volumn 1, Issue 3, 2010, Pages 135-137

  Sanz, Yolanda ^a  

^a INSTITUTO DE AGROQUÍMICA Y TECNOLOGÍA DE ALIMENTOS CSIC   (Spain)

Author keywords

Celiac disease; Gluten free diet; Gut microbiota; Immunity; Polysaccharides; Prebiotics; Probiotics

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 8; POLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ADULT; ARTICLE; BIFIDOBACTERIUM LONGUM; CELIAC DISEASE; CLINICAL ARTICLE; COUNSELING; DIETARY INTAKE; ESCHERICHIA COLI; FECES ANALYSIS; FECES MICROFLORA; GLUTEN FREE DIET; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INTESTINE FLORA; LACTOBACILLUS; MUCOSAL IMMUNITY; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; BACTERIUM; BACTERIUM ADHERENCE; CLINICAL TRIAL; DIET THERAPY; DRUG EFFECT; FECES; FEMALE; HEALTH STATUS; IMMUNOLOGY; INTESTINE; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY;

ADULT; BACTERIA; BACTERIAL ADHESION; CELIAC DISEASE; CYTOKINES; DIET, GLUTEN-FREE; FECES; FEMALE; HEALTH STATUS; HUMANS; INTESTINES; MALE;

EID: 77954832695     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: 10.4161/gmic.1.3.11868     Document Type: Article

References (23)

1. Martens EC, Koropatkin NM, Smith TJ, Gordon JI. Complex glycan catabolism by the human gut microbiota: the Bacteroidetes Sus-like paradigm. J Biol Chem 2009; 284:24673-7.
2. Ley RE, Lozupone CA, Hamady M, Knight R, Gordon JI. Worlds within worlds: evolution of the vertebrate gut microbiota. Nat Rev Microbiol 2008; 6:776-88.
3. Liszt K, Zwielehner J, Handschur M, Hippe B, Thaler R, Haslberger AG. Characterization of bacteria, clostridia and bacteroides in faeces of vegetarians using qPCR and PCR-DGGE fingerprinting. Ann Nutr Metab 2009; 54:253-7.
4. Meresse B, Ripoche J, Heyman M, Cerf-Bensussan N. Celiac disease: from oral tolerance to intestinal inflammation, autoimmunity and lymphomagenesis. Mucosal Immunol 2009; 2:8-23.
5. Bürk K, Farecki ML, Lamprecht G, Roth G, Decker P, Weller M, et al. Neurological symptoms in patients with biopsy proven celiac disease. Mov Disord 2009; 24:2358-62.
6. Capriles VD, Martini LA, Arêas JA. Metabolic osteopathy in celiac disease: importance of a gluten-free diet. Nutr Rev 2009; 67:599-606.
7. Malterre T. Digestive and nutritional considerations in celiac disease: could supplementation help? Altern Med Rev 2009; 14:247-57.
8. Nadal I, Donat E, Ribes-Koninckx C, Calabuig M, Sanz Y. Imbalance in the composition of the duodenal microbiota of children with coeliac disease. J Med Microbiol 2007; 56:1669-74.
9. Collado MC, Donat E, Ribes-Koninckx C, Calabuig M, Sanz Y. Imbalances in faecal and duodenal Bifidobacterium species composition in active and non-active coeliac disease. BMC Microbiol 2008; 22:232.
10. Collado MC, Donat E, Ribes-Koninckx C, Calabuig M, Sanz Y. Specific duodenal and faecal bacterial groups associated with paediatric coeliac disease. J Clin Pathol 2009; 62:264-9.
11. De Palma G, Nadal I, Collado MC, Sanz Y. Effects of a gluten-free diet on gut microbiota and immune function in healthy adult human subjects. Br J Nutr 2009; 102:1154-60.
12. Hurrell E, Kucerova E, Loughlin M, Caubilla-Barron J, Hilton A, Armstrong R, et al. Neonatal enteral feeding tubes as loci for colonisation by members of the Enterobacteriaceae. BMC Infect Dis 2009; 1:146.
13. Collins SM, Denou E, Verdu EF, Bercik P. The putative role of the intestinal microbiota in the irritable bowel syndrome. Dig Liver Dis 2009; 27:85-9.
14. De Palma G, Cinova J, Stepankova R, Tuckova L, Sanz Y. Bifidobacteria and Gram-negative bacteria differentially influence immune responses in the proinflammatory milieu of coeliac disease. J Leuk Biol 2009; in press.
15. Medina M, Izquierdo E, Ennahar S, Sanz Y. Differential immunomodulatory properties of Bifidobacterium logum strains: relevance to probiotic selection and clinical applications. Clin Exp Immunol 2007; 150:531-8.
16. Ménard O, Butel MJ, Gaboriau-Routhiau V, Waligora-Dupriet AJ. Gnotobiotic mouse immune response induced by Bifidobacterium sp. strains isolated from infants. Appl Environ Microbiol 2008; 74:660-6.
17. Duncan SH, Belenguer A, Holtrop G, Johnstone AM, Flint HJ, Lobley GE. Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrate-producing bacteria in feces. Appl Environ Microbiol 2007; 73:1073-8.
18. Flint HJ, Bayer EA, Rincon MT, Lamed R, White BA. Polysaccharide utilization by gut bacteria: potential for new insights from genomic analysis. Nat Rev Microbiol 2008; 6:121-31.
19. Barboza M, Sela DA, Pirim C, Locascio RG, Freeman SL, German JB, et al. Glycoprofiling bifidobacterial consumption of galacto-oligosaccharides by mass spectrometry reveals strain specific, preferential consumption of glycans". Appl Environ Microbiol 2009; [Epub ahead of print].
20. De Graaf AA, Venema K. Gaining insight into microbial physiology in the large intestine: a special role for stable isotopes. Adv Microb Physiol 2008; 53:73-168.
21. Schell MA, Karmirantzou M, Snel B, Vilanova D, Berger B, Pessi G, et al. The genome sequence of Bifidobacterium longum reflects its adaptation to the human gastrointestinal tract. Proc Natl Acad Sci USA 2002; 99:14422-7.
22. Goodman AL, McNulty NP, Zhao Y, Leip D, Mitra RD, Lozupone CA, et al. Identifying genetic determinants needed to establish a human gut symbiont in its habitat. Cell Host Microbe 2009; 6:279-89.
23. Hermes RG, Molist F, Ywazaki M, Nofrarías M, Gomez de Segura A, Gasa J, et al. Effect of dietary level of protein and fiber on the productive performance and health status of piglets. J Anim Sci 2009; 87:3569-77.